| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 42.99 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.22 |
EPS(TTM) : 51.73 |
|
Book Value(₹) : 855.71 |
Market Cap(₹Cr) : 62,766.77 |
Face Value(₹) : 1.00 |
| Board Of Directors | |
|---|---|
| Chairman / Executive Director / M D / Promoter |
Glenn Saldanha
|
| Company Secretary / Compliance Officer |
Rashmi Khandelwal.
|
| Executive Director & Group CFO |
Anurag Mantri
|
| Executive Director (Corporate) |
Cheryl Pinto
|
| Independent Non Exe. Director |
Sona Saira Ramasastry
Dipankar Bhattacharjee
V R Iyer
Pradeep Kumar Sinha
Patricia Andrews
|
| Non Executive Director |
B E Saldanha
|
